Levocetirizine Solution (Levocetirizine Hydrochloride)
Levocetirizine Hydrochloride 0.05g
Solution · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
MFDS item code 201504834 · Notified 2015.07.14 · Insurance code 649102831
Relief of itching associated with allergic rhinitis, chronic idiopathic urticaria, dermatitis, and eczema
This medication is used to relieve symptoms of seasonal or perennial allergic rhinitis. It is also effective in reducing symptoms of chronic idiopathic urticaria. Additionally, it is used in combination with hydrocortisone topical agents for the treatment of dermatitis and eczema with itching in adults and children over 6 years old. This drug helps improve a variety of allergy and skin symptoms.
Adults: Administer orally 5mg of levocetirizine hydrochloride (10mL as oral solution) once daily, with or without food. For adults with renal impairment, adjust the dose according to renal function (estimated glomerular filtration rate (eGFR)). Normal renal function ≥ 90: 5mg per dose, once daily Mild renal impairment 60 -< 90: 5mg per dose, once daily Moderate renal impairment 30 -< 60: 5mg per dose, once every 2 days Severe renal impairment 15 -< 30: Not requiring dialysis. 5mg per dose, once every 3 days End-stage renal disease < 15: Requiring dialysis; contraindicated
Children aged 6 years and older: Administer orally 5mg of levocetirizine hydrochloride (10mL as oral solution) once daily, with or without food. Children aged 2 years and older but under 6 years: Administer orally 1.25mg (2.5mL as oral solution) twice daily. Children aged 1 year and older but under 2 years: Administer orally 1.25mg (2.5mL as oral solution) once daily. Infants under 1 year of age: Do not administer due to limited experience with use. For pediatric patients with renal impairment, reduce the dose according to renal function and body weight.
This medication should not be administered to patients who have allergic reactions to specific ingredients or have a history of hypersensitivity to hydroxizine or piperazine derivatives. Patients with end-stage renal disease or those undergoing dialysis should not use this medication for safety reasons. It is advised not to use this medication in infants under 1 year of age, and for children under 6 years, administration in liquid form is recommended instead of tablets. The liquid formulation contains maltitol, so patients with congenital fructose intolerance should not use this medication. Patients with impaired kidney or liver function, as well as the elderly, should use this medication with caution as it may lead to increased blood concentration. This medication can cause central nervous system symptoms such as drowsiness, headache, dizziness, and fatigue; therefore, caution is necessary when driving or operating machinery. Gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea may occur; rarely, cardiac arrhythmias or hematological adverse reactions may also occur. Allergic reactions such as skin rash, itching, and swelling can manifest; if any unusual symptoms occur, immediate consultation with a physician is recommended. Due to its effect on the central nervous system, it is advisable to avoid taking this medication with alcohol or other central nervous system depressants. Particular caution is needed when administering this medication to patients with urinary retention risks, such as those with prostatic hyperplasia. Patients with epilepsy or at risk of seizures should use this medication carefully as symptoms may worsen following use. Pregnant women should use this medication cautiously under a doctor's guidance due to limited safety data. Breastfeeding women should be aware that this medication may be excreted in breast milk, which could lead to adverse reactions in infants. Children and the elderly should have their dosages adjusted based on kidney function, and any adverse reactions should be immediately reported to medical personnel. It is good practice to stop taking this medication before allergy testing, and in the event of an overdose, as there is no specific antidote, appropriate treatment should be sought based on symptoms.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly sealed container that prevents light exposure. Additionally, it is preferable to store the medication at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the effectiveness and safety of the medication.
A colorless, transparent solution in a brown glass or plastic bottle
500mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Levocetirizine Hydrochloride 0.05g
Solution · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Levocetirizine Hydrochloride 5mg
Tablet · Prescription medication
HanKook UCB Pharma Co., Ltd.
Levocetirizine Hydrochloride 50mg
Solution · Prescription medication
Korea UCB Pharmaceutical Co., Ltd.

Levocetirizine Hydrochloride 5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Levocetirizine Hydrochloride 5mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Levocetirizine Hydrochloride 5mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Levocetirizine Hydrochloride 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Levocetirizine Hydrochloride 5mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.